BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2467639)

  • 1. [Effects of AA-673 on antigen-induced histamine release from leukocytes in patients with allergic rhinitis].
    Takenaka H; Shoji H; Mizukoshi F; Kushumi T; Matsumoto T; Kuriki H
    Arerugi; 1988 Nov; 37(11):1094-100. PubMed ID: 2467639
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory effect of AA-673 eye drops on ocular provocation for Japanese cedar pollinosis].
    Sakuma Y; Mita H
    Arerugi; 1989 Feb; 38(2):93-7. PubMed ID: 2473725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory action amlexanox on interleukin-3-induced enhancement of histamine releasability of human leukocytes].
    Urisu A; Iimi K; Kondo Y; Horiba F; Masuda S; Tsuruta M; Yazaki T; Torii S
    Arerugi; 1990 Oct; 39(10):1448-54. PubMed ID: 1701989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms of hypersensitivity phenomena. XV. Enhancement of passive sensitization of human leukocytes by heparin.
    Levy DA; Osler AG
    J Immunol; 1967 Dec; 99(6):1062-7. PubMed ID: 4168657
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study on basophil histamine release and skin testing in children with allergic rhinitis.
    Kazimierczak W; Zieliński A; Szabelska D
    Arch Immunol Ther Exp (Warsz); 1980; 28(6):935-9. PubMed ID: 6167243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a gamma globulin-histamine complex in the treatment of pollen-induced rhinitis].
    Gumowski P; Petitpierre M; Girard JP
    Schweiz Rundsch Med Prax; 1983 May; 72(20):700-2. PubMed ID: 6192425
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R; Pagano C; Low JL; Church MK; Crimi N
    Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergic alteration of the leukocytes in patients with pollenosis].
    Medunitsyn NV; Gervazieva VB
    Biull Eksp Biol Med; 1967 Jun; 63(6):77-80. PubMed ID: 5622618
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative trial of anti-allergy preparations in subjects allergic to pollen].
    Wohlzogen FX; Wodniansky P
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):359-65. PubMed ID: 4189097
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hydroxyethylated derivatives of rutoside do not liberate tissue histamine in humans].
    Mélon J; Lecomte J
    C R Seances Soc Biol Fil; 1970; 164(3):687-9. PubMed ID: 4099866
    [No Abstract]   [Full Text] [Related]  

  • 11. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antigen-induced leukotriene and histamine release from nasal scrapings in allergic rhinitis.
    Kunitomo M; Otsuka H
    Rhinology; 2005 Sep; 43(3):199-204. PubMed ID: 16218513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effects of histaglobin on allergic rhinitis].
    Matsui T; Sato F; Takenouchi S
    Jibiinkoka; 1970 Nov; 42(11):971-2. PubMed ID: 4097843
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes.
    Tani H; Hasumi K; Tatefuji T; Hashimoto K; Koshino H; Takahashi S
    Bioorg Med Chem; 2010 Jan; 18(1):151-7. PubMed ID: 19942440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The in-vitro histamine liberation in human leukocytes sensitized by grass pollen. Pharmacological application of the study on racephedrine and theophylline (proceedings)].
    Biot N; Kofman J; Grosclaude M; Perrin-Fayolle M
    Acta Allergol; 1977 Jun; 32(3):221-2. PubMed ID: 70946
    [No Abstract]   [Full Text] [Related]  

  • 16. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
    Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
    Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo effect of theophylline on histamine release from human leucocytes.
    Leffert F
    Clin Allergy; 1974 Sep; 4(3):301-6. PubMed ID: 4138988
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorphenesin: a new inhibitor of IgE-mediated histamine release.
    Lichtenstein LM; Adkinson NF
    J Immunol; 1969 Oct; 103(4):806-8. PubMed ID: 4186918
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlorphenesin: a new inhibitor IgE-mediated histamine release.
    Lichtenstein LM; Adkinson NF
    J Immunol; 1969 Oct; 103(4):866-8. PubMed ID: 4195914
    [No Abstract]   [Full Text] [Related]  

  • 20. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
    Schmidt BM; Kusma M; Feuring M; Timmer WE; Neuhäuser M; Bethke T; Stuck BA; Hörmann K; Wehling M
    J Allergy Clin Immunol; 2001 Oct; 108(4):530-6. PubMed ID: 11590377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.